Home > News > Harris & Harris Looks to Separate
September 21st, 2006
Harris & Harris Looks to Separate
Abstract:
Jack Uldrich: Evolved Nanomaterials Sciences (ENS), a private nanotechnology start-up in which Harris & Harris (Nasdaq: TINY) has an equity stake, announced last week that it was releasing a new technology it says would allow chemists to separate, screen, purify, and enrich chiral molecules at a much faster rate than existing technology.
Source:
fool.com
Bookmark:
Harris & Harris
Evolved Nanomaterials Sciences
Possible Futures
Space Solar Power: Key to a Livable Planet Earth June 10th, 2013
Global Nanotechnology Drug Delivery Market 2012-2016 June 10th, 2013
Nanorobot tetanus treatment animation June 9th, 2013
New horizons to drive the future of Medicine: European Technology Platform on Nanomedicine intends to lead the domain June 8th, 2013
Investments/IPO's/Splits
QWave Fund Powers Physics and Materials Science-Based Innovation With Initial Round of Venture Capital Investments: New VC Fund Invests Total of $7M in Nano-Meta Technologies, Centice and Clifton June 19th, 2013
Nanometrics Announces Participation in 5th Annual CEO Investor Summit: Accredited Investor and Publishing Research Analyst Event to be Held Concurrently With SEMICON West and Intersolar 2013 in San Francisco June 19th, 2013
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
Harris & Harris Group Notes Carl Zeiss' Planned Acquisition of Xradia June 13th, 2013
Nanomedicine
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013